Trademark: 98230486
Word
IVRAXENIV
Status
Pending
Status Code
688
Status Date
Tuesday, September 3, 2024
Serial Number
98230486
Mark Type
4
Filing Date
Thursday, October 19, 2023
Published for Opposition
Tuesday, July 9, 2024

Trademark Owner History
IMMVIRA CO., LIMITED - Owner At Publication

Classifications
5 Antiseptics; Biological preparations for the treatment of cancer; Human vaccine preparations; Immunostimulants; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Oral vaccine preparations; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical preparations, namely, antivirals; Vaccine preparations; Vaccines; Viral vaccines

Trademark Events
Oct 19, 2023
New Application Entered
Jan 7, 2024
New Application Office Supplied Data Entered
Jun 4, 2024
Assigned To Examiner
Jun 4, 2024
Approved For Pub - Principal Register
Jun 19, 2024
Notification Of Notice Of Publication E-Mailed
Jul 9, 2024
Published For Opposition
Jul 9, 2024
Official Gazette Publication Confirmation E-Mailed
Sep 3, 2024
Noa E-Mailed - Sou Required From Applicant

Trademark Alertz updated from USPTO on 2030-01-24